2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...
Çö´ëÀÚµ¿Â÷, »ó¿ë»ç¾÷º»ºÎ ½ÅÀÔ »ó½Ã ä¿ë Áß (2019-04-19)
Çö´ëÂ÷, Àü¹®°¡¿Í ÇÔ²²ÇÏ´Â AI °æÁø´ëȸ °³ÃÖ (2022-06-14)
ÀÚ±â°è¹ßºñ Áö¿øÇÏ´Â ½´ÆÛ±â¾÷µé (2019-03-17)
°³¹Ìâ°í, ±¹Åä±³ÅëºÎ Àå°üǥâ ¼ö»ó (2021-11-12)
ºñÀÚ, Áß¼Ò±â¾÷µéÀÌ ±Û·Î¹ú È®Àå ¼ºÀåÀÇ ÇÙ½ÉÀ¸·Î ÁÖ¸ñ (2023-09-26)
ºñÀÚ ÅäÅ« ¹ßÇà·®, ½Ç¹° Ä«µå À¯Åë·® »óȸ (2022-08-27)
ÇÑ俵, µ¥Àϸ®Äɾî Ä¡¾à ¡®¿ø´õÆ®·»µåWTÄ¡¾à¡¯ ¼Ò°³ (2020-03-13)
Á¦19ȸ ÆÄÁÖÃâÆÇµµ½Ã ¾î¸°ÀÌÃ¥ÀÜÄ¡ (2021-04-12)
NEC¿Í »ï¼ºÀüÀÚ, 5G ºÎ¹® ÆÄÆ®³Ê½Ê °è¾à (2018-10-28)
Áö¹æ°ø¹«¿ø, À۳⺸´Ù 3,474¸í ´õ »Ì´Â´Ù (2015-02-08)
½ºÆ¿½Ã¸®Áî, Arctis1 °ÔÀÌ¹Ö Çìµå¼Â ±¹³» Ãâ½Ã (2019-07-10)
»ï¼ºÀüÀÚ, 2022³âÇü »ç¿îµå¹Ù ±¹³» Ãâ½Ã (2022-04-09)
Toshiba Develops Two New Process Technologies for Microcontr... (2015-07-06)
ÇÑÆò, °Ç¹°º° Àü¸Å¡¤ÀÓ´ë ÄÚ³Ê ¿ÀÇ (2023-05-09)
JM¼Ö·ç¼Ç, '¹ö´×½ã°ü·Ã ³í¶õ ÀüÇô ¹«°ü' ÀÔÀå ¹ßÇ¥ (2019-05-05)
°¡¼ö ¾çÆÄ, ¡®¾çÆÄ ½£¡¯ Á¶¼º Çà»ç¿¡ ÆÒµé°ú ÇÔ²² (2015-07-14)
Á¤ºÎ¿Í Çаè, Á¦¾à°­±¹ ÇâÇØ Àü¹®Àη ¾ç¼º (2012-11-23)
ÀÌÁö¾È-¹ÚÀºÇý-±è°æ¶õ, ³­ÀÚ È®º¸ ¡®È¸Ãá ÇÁ·ÎÁ§Æ®¡¯ (2020-05-01)
Çö´ëÂ÷±×·ì, ¹Ì±¹ ARC ¾î¿öÁî 3°³ ºÎ¹® ¼ö»ó (2018-10-11)
¾ð´õµ¶½º, Á÷¾÷´É·Â°³¹ß ¿ø°Ý ÈÆ·Ã±â°ü ÀÎÁõ (2021-05-31)
½Ö¿ëÀÚµ¿Â÷, KG Mobility µðÀÚÀÎ °ø¸ðÀü (2023-03-04)
Çö´ëÀÎ 31.8% ¡®ÇÁ¸®ÅÍÁ·¡¯ (2016-06-15)
À¯¸í ¸Þ½ÅÀú ¾÷µ¥ÀÌÆ® ÇÁ·Î±×·¥ À§Àå ÆÄ¹Ö ¾Ç¼ºÄÚµå (2015-10-12)
Ƽ¾Æ½Ã¾Æ Ä¿¸®, Ãâ½Ã 8°³¿ù ¸¸¿¡ 1000¸¸°³ ÆÇ¸Å (2021-11-28)
Àü ¼¼°è ÇÁ¸®·£¼­ 32% ¼ö¿ä »ó½Â (2022-03-15)
       [ÀÌÀü][1]....[2534][2535][2536][2537][2538][2539][2540][2541][2542]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..